...
【24h】

Phosphate, urea and creatinine clearances: haemodialysis adequacy assessed by weekly monitoring

机译:磷酸盐,尿素和肌酐清除率:每周监测评估血液透析充分性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. The specific distribution of phosphate and the control mechanisms for its plasma level makes phosphate kinetics during haemodialysis (HD) considerably different from those of urea and creatinine and makes the quantitative evaluation of adequacy of phosphate removal difficult. We propose the application of equivalent continuous clearance (ECC) as a phosphate adequacy parameter and compare it with ECC for creatinine and urea. Methods. Three consecutive dialysis sessions were evaluated for 25 patients on maintenance HD. Concentrations of phosphate, urea and creatinine in plasma were measured every 1 h during the treatment and 45 min after, and every 30 min in dialysate. ECC was calculated using the removed solute mass assessed in dialysate and weekly solute profile in plasma. Similar calculations were performed also for the midweek dialysis session only. Different versions of the reference concentration for ECC were applied.
机译:背景。磷酸盐的特定分布及其血浆水平的控制机制使血液透析(HD)过程中的磷酸盐动力学与尿素和肌酐的动力学显着不同,并且难以定量评估磷酸盐去除的充分性。我们建议应用等效连续清除率(ECC)作为磷酸盐适当性参数,并将其与肌酐和尿素ECC进行比较。方法。对维持HD的25例患者进行了3次连续透析。在治疗过程中每隔1小时,透析后45分钟和透析液中每30分钟测量一次血浆中磷酸盐,尿素和肌酐的浓度。使用通过透析液评估的去除的溶质质量和血浆中每周的溶质曲线计算ECC。仅在周中的透析阶段也进行了类似的计算。使用了不同版本的ECC参考浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号